The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease

Haffner, Steven M

doi:10.2337/diacare.20.4.469

Article navigation

Editorials| April 01 1997

The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease

Steven M Haffner, MD

Department of Medicine, University of Texas Health Science Center

San Antonio, Texas

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address correspondence to Steven M. Haffner, MD, Department of Medicine, University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873.

Diabetes Care 1997;20(4):469–471

https://doi.org/10.2337/diacare.20.4.469

PubMed:

9096961

The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease Free

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only

The Scandinavian Simvastatin Survival Study (4S) Subgroup Analysis of Diabetic Subjects: Implications for the Prevention of Coronary Heart Disease